SIME strengthens board to prepare for commercialisation
yahoo.com
finance
2022-10-19 07:00:00

Morten Henneveld, a life science executive with decades of commercial and operations experience, joins SIME board as company prepares for Clinical AI Platform product launch in 2023.

LONDON, Oct. 19, 2022 /PRNewswire/ -- SIME Diagnostics, a pioneer in point-of-care respiratory diagnostics in the ICU, today announced the appointment of Morten Henneveld to the company's Board of Directors.

"Morten's experience in commercialising and scaling innovative technologies to improve health outcomes aligns well with our mission, making him an ideal addition to our Board of Directors," said company CEO Povl Verder.
